Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

GREGOR Tomáš BOSÁKOVÁ Michaela NITĂ Alexandru POOVAKULATHU ABRAHAM Sara FAFÍLEK Bohumil ČERNOHORSKÁ Nicole RYNEŠ Jan TRANTÍRKOVÁ Silvie ŽÁČKOVÁ Daniela MAYER Jiří TRANTÍREK Lukáš KREJČÍ Pavel

Year of publication 2020
Type Article in Periodical
Magazine / Source Cellular and molecular life sciences
MU Faculty or unit

Faculty of Medicine

Citation
Web https://link.springer.com/article/10.1007/s00018-019-03397-7
Doi http://dx.doi.org/10.1007/s00018-019-03397-7
Keywords BCR-ABL; Chronic myeloid leukemia; Signaling; Protein complex
Description Many patients with chronic myeloid leukemia in deep remission experience return of clinical disease after withdrawal of tyrosine kinase inhibitors (TKIs). This suggests signaling of inactive BCR-ABL, which allows the survival of cancer cells, and relapse. We show that TKI treatment inhibits catalytic activity of BCR-ABL, but does not dissolve BCR-ABL core signaling complex, consisting of CRKL, SHC1, GRB2, SOS1, cCBL, p85a-PI3K, STS1 and SHIP2. Peptide microarray and co-immunoprecipitation results demonstrate that CRKL binds to proline-rich regions located in C-terminal, intrinsically disordered region of BCR-ABL, that SHC1 requires pleckstrin homology, src homology and tyrosine kinase domains of BCR-ABL for binding, and that BCR-ABL sequence motif located in disordered region around phosphorylated tyrosine 177 mediates binding of three core complex members, i.e., GRB2, SOS1, and cCBL. Further, SHIP2 binds to the src homology and tyrosine kinase domains of BCR-ABL and its inositol phosphatase activity contributes to BCR-ABL-mediated phosphorylation of SHC1. Together, this study characterizes protein-protein interactions within the BCR-ABL core complex and determines the contribution of particular BCR-ABL domains to downstream signaling. Understanding the structure and dynamics of BCR-ABL interactome is critical for the development of drugs targeting integrity of the BCR-ABL core complex.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info